Cholecystokinin (CCK) has been suggested to be a contributory mediator in acute pancreatitis (AP). The aim of the present study was to assess the role of CCK in the development of oxidative stress at different stages of AP induced by pancreatic duct obstruction (PDO) in rats, using L364,718 (a potent CCK-receptor antagonist) to block CCK action. Intra-acinar oxygen free radical (OFR) generation was analysed by flow cytometry using dihydrorhodamine-123 as a fluorogenic dye. Parallel measurements of pancreatic levels of reduced glutathione (GSH) and of several parameters for the diagnosis of AP were performed in both untreated PDO rats and PDO rats receiving L364,718 (0.1 mg · 12 h −1 · kg −1 ). Diagnosis parameters indicated a greater severity of AP in rats treated with the CCK antagonist. The increase in OFR generation observed in acinar cells up to 12 h after inducing AP was triggered at an earlier stages and reached higher values when L364,718 was administered. Accordingly, greater pancreatic GSH depletion was observed in rats with AP treated with the CCK antagonist. Two populations of acinar cells that were differentiated by flow cytometry, R1 and R2, showed similar behaviour with regard to OFR generation in PDO rats; however, R1 cells showed greater sensitivity to L364,718 administration, and thus OFR production was increased in R1 cells earlier than in R2 cells. In conclusion, CCK blockade anticipates and enhances the amount of OFR produced in acinar cells as a consequence of AP, thus leading to earlier development of and more severe disease. The detrimental effect of L364,718 in AP induced by PDO suggests that plasma CCK does not play a major role in the development of this AP model.
INTRODUCTION
Although the intrapancreatic activation of digestive enzymes is widely accepted as an initial event in the development of acute pancreatitis (AP) [1, 2] , other mechanisms are also involved. Oxygen free radicals (OFR) have been reported to be critical mediators in the pathogenesis of AP [3] [4] [5] [6] . The depletion of pancreatic glutathione (GSH) -one of the main cellular antioxidants [7] -as well as enhanced levels of some metabolites from membrane lipid peroxidation are common features of AP, suggesting the generation of an excess of OFR in the pancreas. However, little attention has been devoted to the analysis of OFR generated within acinar cells in order to ascertain the individual cellular contribution to oxidative damage during AP. It has also been suggested that the gastrointestinal hormone cholecystokinin (CCK) plays a permissive or even a contributory role in the development of AP [8] [9] [10] . As a consequence of the secretory blockade induced by AP [11] [12] [13] [14] , the feedback mechanism for CCK release exerted by pancreatic proteases from duodenal lumen is abolished [15, 16] , thus leading to an increase in circulating CCK concentrations [17] . It has been hypothesized that high plasma levels of CCK could overstimulate the pancreas, thereby worsening the progression of the disease [8] [9] [10] . On this basis, many studies have been performed to examine the effects of various CCK receptor antagonists on AP [9, 10, [18] [19] [20] [21] [22] , which have led to highly controversial results. The influence of CCK blockade on intracellular mechanisms involved in AP need to be analysed in order to ascertain the cause of the final effects of the CCK antagonists.
In the present study, L364,718, a highly specific CCK-A receptor antagonist [23] , was administered to rats with AP induced by obstruction of the common bilepancreatic duct. Our aim was to evaluate the influence of CCK blockade on the amounts of OFR generated in individual acinar cells at different stages of AP, in order to clarify the role of CCK in the disease, and to examine whether the influence exerted by the CCK antagonist on oxidative stress could explain its modulatory effects on the severity of the disease.
MATERIALS AND METHODS

Chemicals
Pharmingen (San Diego, CA, U.S.A.) supplied an ELISA kit for tumour necrosis factor-α (TNF-α). Collagenase type VII, soybean trypsin inhibitor, amino acid mixture, BSA, dihydrorhodamine-123 (DHR), Hepes, glutathione, NADPH, glutathione reductase type III, EDTA and 5,5 -dithio-bis-(2-nitrobenzoic acid) (DTNB) were supplied by Sigma Chemical Co. (Madrid, Spain). L364,718 was kindly donated by Merck & Dohme (Madrid, Spain). Other standard analytical-grade laboratory reagents were obtained from Merck (Darmstadt, Germany).
Surgical procedure
Male Wistar rats weighing 250-300 g were used. After a 12 h fast, the rats were anaesthesized with ether and AP was induced by ligation of the common bilepancreatic duct at the distal part, close to its exit to the duodenum. After closing the abdomen with nonadsorbable sutures, the animals were placed back in their cages with free access to food and water. In sham-operated animals, the bile-pancreatic duct was dissected but not ligated. Post-operative analgesia was maintained in all animals by subcutaneous injections of buprenorphine (0.2 mg · 8 h −1 · kg −1 ).
Animal groups
Animal experiments were conducted with the approval of the Animal Care Committee of Salamanca University, in accordance with the European Union guidelines for ethical animal research. Rats were randomly divided into four groups. Group I comprised rats with pancreatic duct obstruction (PDO), achieved by ligating the common bile-pancreatic duct for 0 h (n = 10), 1.5 h (n = 14), 3 h (n = 11), 6 h (n = 15), 12 h (n = 14), 24 h (n = 10) or 48 h (n = 11). The time point at 0 h represents intact animals that served as a control group. Group II was composed of shamoperated rats treated surgically as for group I, but with the pancreatic duct not ligated. They were studied after 1.5 h (n = 10), 3 h (n = 10), 6 h (n = 10), 12 h (n = 10), 24 h (n = 12) or 48 h (n = 10). Group III was composed of rats that received one intraperitoneal injection of L364,718 (0.1 mg/kg) resuspended in 0.15 M NaCl, 30 min before the ligation of the bile-pancreatic duct, followed by a second subcutaneous injection of L364,718 resuspended in 10 % (v/v) DMSO solution in 0.15 M NaCl immediately after ligation. Rats were studied at 1.5 h (n = 13), 3 h (n = 12), 6 h (n = 11), 12 h (n = 12), 24 h (n = 10) or 48 h (n = 11). In order to maintain the action of the CCK-receptor antagonist, subcutaneous injections of L364,718 in 10 % (v/v) DMSO were administered every 12 h after PDO in the final two subgroups. Group IV consisted of sham-operated rats which received L364,718 as described for group III, and were studied at 1.5 h (n = 9), 3 h (n = 8), 6 h (n = 8), 12 h (n = 9), 24 h (n = 11) and 48 h (n = 12) after the surgical procedure.
Collection of samples
After overnight fasting, laparotomy was performed and the peritoneal fluid (ascites) was collected by aspiration. Blood samples were taken by cardiac puncture to determine plasma amylase activity and plasma TNF-α levels. Finally, the entire pancreas was removed to determine the percentage of fluid, for measurement of levels of GSH or for the isolation of pancreatic cells. Different animals were used either for GSH measurements or for isolation of acinar cells.
Electron microscopy studies
Portions of pancreatic tissue were examined by electron microscopy. Samples were prefixed with 0.1 M cacodylate buffer, pH 7.4, containing 2 % (v/v) glutaraldehyde at 4
• C for 2 h, and then postfixed with 2 % OsO 4 in the same buffer, dehydrated in ethanol and finally embedded in Epon. Ultrathin sections were prepared, stained with uranyl acetate and lead citrate, and examined with a Zeiss electron microscope (EM 900). Multiple blinded sections were evaluated and representative findings were used for photoreprints.
Assays
Indicators of pancreatitis
Plasma amylase activity was determined using the method of Noelting and Bernfeld [24] . The amount of tissue fluid was calculated by drying the pancreas at 100
• C for 72 h. Plasma TNF-α levels were measured using an ELISA, strictly following the recommendations of the manufacturer.
Measurement of GSH levels in the pancreas
After homogenizing the pancreas in 5 % (v/v) 5-sulphosalicylic acid, the GSH content was measured using the specific technique described by Tietze [25] , based on spectrophotometric monitoring of the glutathionemediated reduction of DTNB at 412 nm.
Preparation of isolated cells
After a median laparotomy, the bile duct was ligated at its exit from the liver and the main pancreatic duct was cannulated at its exit into the duodenum, followed by perfusion of 5 ml of 25 mM Hepes solution, pH 7.4, containing collagenase (40 units/ml), 0.1 mg/ml soybean trypsin inhibitor, 100 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 14 mM d-glucose, 2 mM glutamine, 2 % (w/v) BSA and 2 % (w/v) amino acid mixture. The solution was preincubated in 95 % O 2 /5 % CO 2 and all further incubations were performed with this gas phase. The pancreas was digested at 37
• C in a shaking bath (200 cycles/min) for 20 min and washed with fresh collagenase solution every 5 min. Following gentle pipetting through tips of decreasing diameter (3 to 1 mm), cells were filtered through a double layer of muslin gauze and then centrifuged at 30 g for 30 s at 4
• C. The supernatant was collected and centrifuged at 500 g for 5 min at 4
• C. The supernatant was discarded and the cell pellet was resuspended in Hepes buffer without collagenase. After this isolation procedure, mostly single cells [(25-30) × 10 6 /pancreas] were obtained, as well as some small clusters consisting of up to five cells. The labelling of isolated cells with specific antisera against digestive enzymes assessed the purity of acinar cells as 99 % [26] . Cell viability monitored with Trypan Blue was always greater than 95 %, and this was not significantly decreased by H 2 O 2 , at least during the duration of the experiments for verifying stability in DHR dye.
Analysis of OFR generation in acinar cells
Oxidative stress in individual acinar cells was measured by using DHR. DHR easily crosses cell membranes and, upon oxidation by OFR, is converted into rhodamine-123 and becomes fluorescent [27] . In order to establish optimal conditions for DHR dye in acinar cells, control experiments were conducted using acinar cells (10 6 ) exposed to 1 mM H 2 O 2 for 30 min at 4
• C. Then 25 mM DHR was added and incubated with the cells at 4
• C in the 
Statistical analysis
Results are expressed as means + − S.E.M. Statistical analysis was carried out using ANOVA followed by Scheffé's test. The paired Student's t test was applied to the results obtained in the two acinar cell populations, R1 and R2. In all cases, P values of < 0.05 were considered to be statistically significant.
RESULTS
Progressive increases in plasma amylase activity were observed from 1.5 h to 24 h after PDO in both L364,718-treated and non-treated rats (Figure 1 ), reaching the highest values 6 h and 12 h after PDO (P < 0.001).
The percentage of fluid in the pancreas rose significantly from 3 h after PDO in both groups of rats, and remained increased at 48 h (P < 0.01), but at 6 h after PDO the percentage of fluid in the pancreas was significantly (P < 0.05) higher in L364,718-treated than it was in nontreated PDO rats. The volume of ascites also increased from the early stages of AP, in both L364,718-treated and non-treated rats; the highest values were reached 6 h (P < 0.05) and 12 h (P < 0.001) after ligation of the bilepancreatic duct. Values obtained at 12 h in L364,718-treated PDO rats were significantly higher (P < 0.001) than they were in non-treated PDO rats. L364,718 administration did not affect plasma amylase, pancreatic fluid or volume of ascites in sham-operated animals. No significant difference between controls and shamoperated rats was found at any time.
Figure 1 Plasma amylase activity, pancreatic fluid and volume of ascites in the different experimental groups
Measurements were performed in control rats (C), sham-operated rats, sham-operated rats receiving L364,718, rats with PDO, and rats with PDO treated with L364,718. The number of animals was 5-8 in each group. Values are means + − S.E.M. ANOVA followed by Scheffé's test applied to the results from controls and sham-operated rats did not reveal significant differences at any time. ANOVA followed by Scheffé's test applied at the different times from 1.5 h to 48 h to the four experimental groups showed significant differences for PDO rats (treated or not with L364,718) compared with sham-operated rats (*P < 0.05, **P < 0.01, ***P < 0.001), and for L364,718-treated compared with untreated PDO rats (᭺P < 0.05, ᭺᭺᭺P < 0.001).
As shown in Figure 2 , plasma TNF-α levels were increased in rats that had undergone PDO from 6 h (P < 0.05) to 48 h (P < 0.001) after AP induction, reaching the highest values in the latter stages. In rats with PDO that received L364,718, the plasma TNF-α concentration was significantly increased as early as 3 h after PDO (P < 0.001). Afterwards, plasma TNF-α levels decreased, remaining slightly higher than in shamoperated rats. No variations in plasma TNF-α levels were found in controls or sham-operated rats treated with L364,718.
Pancreatic glutathione (GSH) content is shown in Table 1 . Significantly decreased GSH levels were found from 3 h (P < 0.05) to 24 h (P < 0.001) after PDO in both L364,718-treated and non-treated rats, but it is noteworthy than the amount of GSH in the pancreas was significantly (P < 0.001) lower at 12 h after PDO in the L364,718-treated rats. Values of GSH levels from shamoperated rats receiving L364,718 did not differ from those of non-treated sham-operated rats.
Electron microscopy images of pancreatic sections (Figures 3 and 4) revealed more severe histological alterations in PDO rats treated with L364,718. Oedema, vacuolization and dilatation of the rough endoplasmic reticulum were greater from early times after PDO in rats treated with the CCK antagonist. Nuclear alterations (shrinkage and apoptosis) were observed 24 and 48 h after PDO in both animal groups, but more severe intracellular disorganization was evident in PDO rats treated with L364,718. Figure 5 shows the detection of OFR produced in acinar cells from control rats exposed to 1 mM H 2 O 2
Table 1 Content of pancreatic GSH
Values are expressed as means + − S.E.M.; n represents the numbers of animals in groups I (PDO rats), II (sham-operated rats), III (PDO rats treated with L364,718) and IV (sham-operated rats treated with L364,718). Significance of differences: *P < 0.05, **P < 0.01, ***P < 0.001 compared with group II; † † †P < 0.001 compared with group I. 
Concentration (µmol/g)
Figure 2 Plasma TNF-α concentrations in the different experimental groups
Measurements were performed in control rats (C), sham-operated rats, shamoperated rats receiving L364,718, rats with PDO, and rats with PDO treated with L364,718. The number of animals was 5-9 in each group. Values are means + − S.E.M. ANOVA followed by Scheffé's test applied to controls and shamoperated rats did not reveal significant differences at any time. ANOVA followed by Scheffé's test applied at the different times from 1.5 h to 48 h to the four experimental groups showed significant differences for PDO rats (treated or not with L364,718) compared with sham-operated rats (***P < 0.001), and for L364,718-treated compared with untreated PDO rats (᭺P < 0.05, ᭺᭺P < 0.01, ᭺᭺᭺P < 0.001).
after different periods of DHR loading. Stability of the DHR dye was found from 15 min onwards. Accordingly, acinar cells were loaded with DHR for 20 min. Figure 6 shows a representative example of the flow cytometric distribution of acinar cells according to FSC (forward or low-light-angle scatter) against DHR dye. Two populations of acinar cells could be observed on the basis of FSC, a parameter related to size [28] . The R2 population showed higher FSC values, being formed by larger cells than the R1 population. With regard to the DHR dye, a high degree of heterogeneity was found in both populations, although R2 cells showed higher values of fluorescence intensity due to DHR than did R1 cells in all animal groups.
Flow cytometric analysis of OFR in individual acinar cells (Figure 7 ) revealed increased DHR dye in acinar cells from PDO rats from 3 to 12 h after obstruction, although the statistical test did not reveal significant differences. The mean fluorescence intensity due to DHR also increased from 1.5 to 12 h after PDO in rats receiving L364,718, reaching statistical significance (P < 0.05) 6 h after PDO. L364,718 administration to sham-operated rats did not significantly alter the amount of cellular DHR dye. When the two different populations of acinar cells were analysed, significantly (P < 0.05) increased DHR dye could be observed in R1 cells from PDO rats treated with the CCK antagonist from 1.5 h after PDO, with values significantly (P < 0.05) higher than in nontreated rats. Significantly increased OFR production was also observed in R2 cells from 3 to 6 h after PDO in L364,718-treated rats. Significant (P < 0.05) differences with respect to the non-treated group were found 6 h after PDO.
With regard to changes in DHR values as a consequence of PDO, no differences were found between the two acinar cell populations in non-treated PDO rats (Figure 8 ), but statistically significant differences (P < 0.01) were found 1.5 and 6 h after PDO in rats treated with L364,718. Higher values were found in R1 cells 1.5 h after PDO, whereas higher OFR production was detected in R2 cells 6 h after AP induction.
DISCUSSION
Although the pathophysiology of AP is still poorly understood, oxidative stress is commonly accepted to be involved in the development of the disease [3] [4] [5] [6] . An excess of OFR in the pancreas has been shown to induce several disorders, such as lipid peroxidation [29] , intracellular protein oxidation [4] , DNA damage [30] and depletion of intracellular antioxidants [5, 6] . On the other hand, circulating levels of CCK have been found to be increased both in experimental models [17] and in human disease [31] ; therefore it has been suggested that CCK worsens the outcome of the disease, since overstimulation of the pancreas has been found to be harmful in AP [32] . On this basis, prophylactic and therapeutic effects have been suggested for several CCK-receptor antagonists, but conflicting results have been obtained [8] [9] [10] [18] [19] [20] [21] [22] .
It is of great interest to establish a relationship between the effects that L364,718 exerts at an intracellular level
Figure 3 Electron microscopic sections of pancreas (× 4400) from rats at 1.5 h (A), 3 h (B), 6 h (C), 12 h (D), 24 h (E) and 48 h (F) after PDO
Dilatation of the endoplasmic reticulum (arrows), oedema (star), vacuolization (arrowheads) and apoptosis (marked A in F) can be observed. and the consequences of administration of this CCK antagonist on the outcome of AP. Here we provide the first evidence indicating that CCK blockade modifies the oxidative condition of the pancreas of rats with AP induced by PDO, a design that represents a useful model with which to study gallstone-induced AP in humans.
Rather than analysing the products of oxidative degradation (malondialdehyde, lipid peroxides), as commonly carried out in other studies, we directly assayed the generation of OFR in individual acinar cells by using DHR as a tool for depicting OFR produced within the cell [27] . Flow cytometric analysis revealed increased OFR generation in acinar cells at early stages of AP, in both L364,718-treated and non-treated rats. Our data clearly indicate that, in addition to OFR produced by activated neutrophils infiltrating into the pancreas [33] , the large number of acinar cells play a pivotal contributory role to the excessive generation of OFR during early AP, thus leading to the spread of cellular damage and gland injury.
Usually, OFR generated within the cell are quickly removed by the cellular defence system, but when OFR production exceeds the normal rate, diminished amounts of antioxidants are found in the tissue. GSH is one of the most important cellular antioxidants [7] , and its depletion seems to be a common feature of AP [3] [4] [5] [6] . Accordingly, diminished levels of pancreatic GSH were found from 3 h to 24 h after PDO, which could be explained either by a decrease in levels of its precursor [6] 
Figure 4 Electron microscopic sections of pancreas (× 4400) from L364,718-treated rats at 1.5 h (A), 3 h (B), 6 h (C), 12 h (D), 24 h (E) and 48 h (F) after PDO
Dilatation of endoplasmic reticulum (arrows), oedema (star), vacuolization (arrowheads) and apoptosis (marked A in F) can be observed. Comparisons between the different groups were made for total, R1 and R2 cells by ANOVA followed by Scheffé's test. Significant differences for PDO rats (treated or not with L364,718) compared with sham-operated rats (*P < 0.05), and for L364,718-treated compared with untreated PDO rats (᭺P < 0.05, ᭺᭺P < 0.01) were found.
or by its use as a reductant factor or in direct detoxification of the excess OFR generated within the cell [34] . Interestingly, higher OFR levels were generated in acinar cells from PDO rats treated with L364,718 and, accordingly, a significantly lower pancreatic GSH content was observed 12 h after PDO in rats treated with the CCK antagonist. Since L364,718 treatment did not induce oxidative stress in the pancreas of sham-operated animals, our results indicate a relationship between the substantial generation of acinar OFR and the greater degree of severity of AP found in rats with pancreatic obstruction treated with the CCK antagonist. These findings suggest that CCK blockade makes acinar cells more vulnerable to the damage induced by PDO, leading to greater oxidative stress. A derangement in intracellular signalling might contribute to this effect. This notion is supported by recent studies in which we reported that L364,718 administration to rats with AP induced by PDO increased cytosolic calcium levels above those in rats with AP not treated with the CCK antagonist [35] . Since the activation of proteases that initiates AP is highly dependent on the concentration of intracellular calcium [36] , greater pancreatic damage associated with oxidative stress would be expected in L364,718-treated rats. Both an increased cytosolic Ca 2+ concentration and greater OFR generation in acinar cells, as early mechanisms involved in the development of AP, would explain the exacerbated pancreatic injury revealed by electron microscopy analysis in rats with PDO after CCK blockade.
Controversial results have been reported for the effects of CCK antagonists on the development of pancreatitis; the present study demonstrates that analysis of intracellular mechanisms is required in order to obtain new insight into their final effects. Moreover, it is noteworthy that L364,718 administration triggered the oxidative response within acinar cells at earlier stages of AP, an event that leads to the activation of the inflammatory cascade, since OFR induce the attraction and adhesion of leucocytes [37, 38] , which in turn enhance OFR production via the respiratory burst. OFR also activate the oxidant-sensitive transcription factor nuclear factor-κB [39] , thus resulting in up-regulation of inflammatory cytokines, as reflected by the greater and earlier increase in plasma TNF-α levels in PDO rats treated with L364,718. An increase in the level of this pro-inflammatory cytokine at early stages of AP would initiate a 'vicious circle', since TNF-α is able to induce oxidative stress [40] and activate nuclear factor-κB [41] .
Although various clinical and experimental studies have demonstrated that the inhibition of pancreatic secretion has a beneficial effect on AP [42, 43] , the present study clearly shows a detrimental effect of CCK blockade in AP induced by PDO, the most common aetiology in human pancreatitis. The data indicate that intracellular events specifically induced by administration of a CCK receptor antagonist anticipate and enhance the amount of OFR generated within acinar cells, thus increasing the oxidative damage produced in the pancreas during the development of AP. In fact, diagnosis parameters indicate that L364,718 accelerated and aggravated the outcome of AP.
Since we studied the time course of OFR generation in acinar cells at different stages of AP, we were able to observe differences in the oxidative response developed by the two cell populations that could be differentiated by flow cytometry on the basis of light scatter properties [26, 44] . Whereas no differences between R1 and R2 cells were found in untreated rats with PDO at any stage of AP, asynchronous generation of OFR could be observed when L364,718 was administered. With regard to enzyme overload [26] and disturbances in Ca 2+ homoeostasis [35, 44] , previous studies have concluded that R1 cells appear to be the most sensitive to damage produced by PDO. This notion is supported by the present results, indicating that the detrimental effects of CCK blockade on the course of AP are apparent earlier in R1 than in R2 cells. Differences in the distribution of plasma membrane glycoconjugates have been observed between the two acinar cell populations [45] , a finding that could relate to their different behaviour, since a high number of hormone receptors have proved to be glycoproteins.
From 24 h after PDO, acinar cells from both L364,718-treated and non-treated rats failed to show increased values of DHR dye. The severe morphological alterations found 24 and 48 h after PDO induction prevented us from considering these decreased levels of DHR dye as indicating an improvement in the disease. In contrast, it is likely that, as a result of the substantial cellular damage incurred, cells would become incapable of producing more OFR. This event would be anticipated in R1 cells from PDO rats treated with L364,718, prematurely damaged by oxidative stress.
In summary, the present study clearly shows a detrimental effect of L364,718 administration in AP induced by PDO, strongly suggesting that CCK does not play a major role in the development of this model of AP. Moreover, we provide the first evidence to indicate that CCK blockade anticipates and enhances the amount of OFR produced in acinar cells as a consequence of AP, thus leading to earlier development of and more severe disease.
